Open AccessAbstract 4169: Inhibition of EphB4-ephrin-B2 signaling results in enhanced sensitivity to cetuximab-radiation therapy in head and neck cancers
Author(s) -
Shilpa Bhatia,
Jaspreet Sharma,
Sanjana Bukkapatnam,
Ayman Oweida,
Shelby Len,
Parkash S. Gill,
Antonio Jimeno,
David Raben,
Lynn E. Heasley,
Sana D. Karam
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-4169
Subject(s) - cetuximab , medicine , cancer research , head and neck cancer , radiation therapy , erythropoietin producing hepatocellular (eph) receptor , immunohistochemistry , egfr inhibitors , cancer , receptor , head and neck squamous cell carcinoma , colorectal cancer , receptor tyrosine kinase , oncology , epidermal growth factor receptor